SCHEMBL1243570

SCHEMBL1243570

CCn1cc(C(=O)NC(C(=O)O)C(C)(C)C)c(=O)c2cc(F)c(NCC3CCCCC3)cc21

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
GAA P10253 4/20 0.56
KDM4E B2RXH2 8/20 0.45
ALDH1A1 P00352 6/20 0.44
LMNA P02545 3/20 0.44
RAD52 P43351 1/20 0.42
HPGD P15428 3/20 0.42
POLB P06746 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
DRD3 P35462 1/20 0.40
GLA P06280 1/20 0.40
BRD4 O60885 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
CYP2J2 P51589 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
FOXO1 Q12778 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242608 0.84 KDM4E (0.52) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1241058 0.84 MEN1 (0.61) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243323 0.77 MEN1 (0.75) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243831 0.73 MEN1 (0.85) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL4111281 0.73 MEN1 (1.00) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243866 0.72 KMT2A (0.81) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243135 0.72 MEN1 (0.65) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL4110428 0.72 MEN1 (0.79) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL1243614 0.69 MEN1 (0.60) MEN1KMT2AGAAKDM4EALDH1A1
SCHEMBL22698659 0.69 HPGD (0.65) MEN1KMT2AGAAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7879878-B2 such as {2-[({[7-(cyclohexylamino)-6-fluoro-4-oxo-1-[(3S)-tetrahydrofuran-3-yl]-1,4-dihydroquinolin-3-yl}carbonyl)amino]ethyl}phosphonic acid, used as platelet aggregation inhibitor and purinergic receptor (P2Y12) inhibitors; therapy for circulatory diseases involving thrombosis via platelet aggregation ASTELLAS PHARMA INC. (JP) 2011-02-01 US disclosed